Progyny Inc (PGNY) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Progyny Inc (PGNY) has a cash flow conversion efficiency ratio of 0.105x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($45.95 Million) by net assets ($439.34 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Progyny Inc - Cash Flow Conversion Efficiency Trend (2017–2025)
This chart illustrates how Progyny Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read how much debt does Progyny Inc carry for a breakdown of total debt and financial obligations.
Progyny Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Progyny Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
OFG Bancorp
NYSE:OFG
|
0.028x |
|
Ennostar Inc
TW:3714
|
0.016x |
|
Metro Investment Development Co Ltd
SHG:600683
|
-0.022x |
|
Yusys Technologies Co Ltd Class A
SHE:300674
|
0.008x |
|
MicroPort Endovascular MedTech Ltd
SHG:688016
|
0.011x |
|
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267
|
0.048x |
|
Formula Systems (1985) Ltd
F:FSY
|
N/A |
|
HUTCHMED (China) Limited
F:H7T1
|
-0.071x |
Annual Cash Flow Conversion Efficiency for Progyny Inc (2017–2025)
The table below shows the annual cash flow conversion efficiency of Progyny Inc from 2017 to 2025. For the full company profile with market capitalisation and key ratios, see Progyny Inc stock valuation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $516.04 Million | $210.19 Million | 0.407x | -4.02% |
| 2024-12-31 | $422.06 Million | $179.10 Million | 0.424x | +24.38% |
| 2023-12-31 | $553.43 Million | $188.81 Million | 0.341x | +59.97% |
| 2022-12-31 | $376.97 Million | $80.39 Million | 0.213x | +106.27% |
| 2021-12-31 | $251.82 Million | $26.04 Million | 0.103x | -52.32% |
| 2020-12-31 | $166.95 Million | $36.20 Million | 0.217x | +1715.39% |
| 2019-12-31 | $114.27 Million | $-1.53 Million | -0.013x | -106.57% |
| 2018-12-31 | $11.12 Million | $2.27 Million | 0.204x | +123.05% |
| 2017-12-31 | $10.69 Million | $-9.47 Million | -0.886x | -- |
About Progyny Inc
Progyny, Inc., a benefits management company, provides fertility, family building, and women's health benefits solutions in the United States. It offers fertility benefits solutions, such as differentiated benefits plan design that includes smart cycle treatment bundle; personalized concierge-style member support services; and a selective network of fertility specialists. The company also offers … Read more